217 related articles for article (PubMed ID: 16869455)
1. Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS).
Maitland-van der Zee AH; Jukema JW; Zwinderman AH; Hallman DM; De Boer A; Kastelein JJ; De Knijff P
Acta Cardiol; 2006 Jun; 61(3):327-31. PubMed ID: 16869455
[TBL] [Abstract][Full Text] [Related]
2. Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).
Klerkx AH; de Grooth GJ; Zwinderman AH; Jukema JW; Kuivenhoven JA; Kastelein JJ
Eur J Clin Invest; 2004 Jan; 34(1):21-8. PubMed ID: 14984434
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between gene polymorphism at the apolipoprotein E locus and serum lipid profile in urban children of school age in Beijing].
Zhu W; Feng N; Wang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):297-300. PubMed ID: 11769625
[TBL] [Abstract][Full Text] [Related]
4. Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week inpatient rehabilitation program.
Vossen CY; Hoffmann MM; Hahmann H; Wüsten B; Rothenbacher D; Brenner H
Clin Pharmacol Ther; 2008 Aug; 84(2):222-7. PubMed ID: 18388879
[TBL] [Abstract][Full Text] [Related]
5. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A;
Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.
Donnelly LA; Palmer CN; Whitley AL; Lang CC; Doney AS; Morris AD; Donnan PT
Pharmacogenet Genomics; 2008 Apr; 18(4):279-87. PubMed ID: 18334912
[TBL] [Abstract][Full Text] [Related]
7. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.
Ferreira CN; Carvalho MG; Fernandes AP; Lima LM; Loures-Valle AA; Dantas J; Janka Z; Palotás A; Sousa MO
Neurochem Int; 2010 Jan; 56(1):177-82. PubMed ID: 19819279
[TBL] [Abstract][Full Text] [Related]
9. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
[TBL] [Abstract][Full Text] [Related]
10. The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects.
Moreno JA; Pérez-Jiménez F; Moreno-Luna R; Pérez-Martínez P; Fuentes-Jiménez F; Marín C; Portugal H; Lairon D; López-Miranda J
Br J Nutr; 2009 Jun; 101(12):1745-52. PubMed ID: 19025720
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against oxidized LDL and apolipoprotein E polymorphism in demented patients.
Bednarska-Makaruk M; Rodo M; Graban A; Lojkowska W; Bochyńska A; Ryglewicz D; Wehr H
J Neurol Sci; 2009 Aug; 283(1-2):137-8. PubMed ID: 19303604
[TBL] [Abstract][Full Text] [Related]
12. Investigating Effects of Plasma Apolipoprotein E on Ischemic Heart Disease Using Mendelian Randomization Study.
Li MY; Kwok MK; Schooling CM
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34203181
[TBL] [Abstract][Full Text] [Related]
13. Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.
MacMahon S; Sharpe N; Gamble G; Hart H; Scott J; Simes J; White H
Circulation; 1998 May; 97(18):1784-90. PubMed ID: 9603532
[TBL] [Abstract][Full Text] [Related]
14. Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol. Regression Growth Evaluation Statin Study (REGRESS) Study Group.
Cobbaert C; Jukema JW; Zwinderman AH; Withagen AJ; Lindemans J; Bruschke AV
J Am Coll Cardiol; 1997 Nov; 30(6):1491-9. PubMed ID: 9362407
[TBL] [Abstract][Full Text] [Related]
15. Association between apolipoprotein E genotypes and panic disorder in Turkish population.
Gulec-Yilmaz S; Gulec H; Ogut DB; Cetin B; Gormus U; Isbir T
Nord J Psychiatry; 2018 Oct; 72(7):477-483. PubMed ID: 29888635
[TBL] [Abstract][Full Text] [Related]
16. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease.
Granér M; Kahri J; Varpula M; Salonen RM; Nyyssönen K; Jauhiainen M; Nieminen MS; Syvänne M; Taskinen MR
Nutr Metab Cardiovasc Dis; 2008 May; 18(4):271-7. PubMed ID: 17462871
[TBL] [Abstract][Full Text] [Related]
18. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
Petrovic D; Zorc M; Peterlin B
Folia Biol (Praha); 2000; 46(5):181-5. PubMed ID: 11055796
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS).
Streja L; Packard CJ; Shepherd J; Cobbe S; Ford I;
Am J Cardiol; 2002 Oct; 90(7):731-6. PubMed ID: 12356386
[TBL] [Abstract][Full Text] [Related]
20. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
